SCHEMBL4064172

SCHEMBL4064172

C#Cc1cncc2c(N)cccc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
HPGD P15428 4/20 0.44
CYP3A4 P08684 3/20 0.44
HSD17B10 Q99714 3/20 0.44
TSHR P16473 2/20 0.44
TDP1 Q9NUW8 2/20 0.44
NR4A2 P43354 2/20 0.41
LMNA P02545 3/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KEAP1 Q14145 1/20 0.39
KDM4E B2RXH2 5/20 0.35
POLB P06746 4/20 0.35
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
TDP2 O95551 2/20 0.35
BLM P54132 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL689722 0.79 ALDH1A1 (0.59) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL29977311 0.79 ALDH1A1 (0.59) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL30668492 0.77 ALDH1A1 (0.62) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL20298332 0.77 ALDH1A1 (0.62) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL13765865 0.77 CYP1A2 (0.44) ALDH1A1HPGDHSD17B10CYP1A2MAPT
SCHEMBL4068083 0.72 AXL (0.55) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL12658241 0.72 ALDH1A1 (0.48) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL688880 0.71 IDO1 (0.46) ALDH1A1HPGDCYP3A4HSD17B10TSHR
SCHEMBL4062748 0.69 HTT (0.44) CYP3A4LMNACYP1A2CYP2D6CYP2C9
SCHEMBL28691598 0.69 PRKCZ (0.51) ALDH1A1HPGDCYP3A4HSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090561-B2 Acetylenic heteroaryl compounds ARIAD PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
US-8461167-B2 Acetylenic heteroaryl compounds ARIAD PHARMACEUTICALS, INC. (US) 2013-06-11 US disclosed
US-20130018046-A1 Acetylenic Heteroaryl Compounds ARIAD PHARMACEUTICALS, INC. (US) 2013-01-17 US disclosed
CN-101489558-A Acetylenic heteroaryl compounds ARIAD PHARMA INC (US) 2009-07-22 CN disclosed
US-20090176781-A1 Acetylenic Heteroaryl Compounds ARIAD PHARMACEUTICALS, INC. 2009-07-09 US disclosed
EP-2023933-A2 ACETYLENIC HETEROARYL COMPOUNDS ARIAD PHARMACEUTICALS, INC. (US) 2009-02-18 EP disclosed
WO-2007133560-A9 ACETYLENIC HETEROARYL COMPOUNDS ARIAD PHARMA INC (US) 2008-11-13 WO disclosed
WO-2007133560-A2 ACETYLENIC HETEROARYL COMPOUNDS ARIAD PHARMACEUTICALS, INC. (US) 2007-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176781-A1 Acetylenic Heteroaryl Compounds NAT1, AADAC, ACACA ALDH1A1 148/4885HPGD 551/4885CYP3A4 48/4885
US-20130018046-A1 Acetylenic Heteroaryl Compounds NAT1, AADAC, ACACA ALDH1A1 148/4885HPGD 551/4885CYP3A4 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.